News

Phenomics Health Advances Precision Medicine with Products that Integrate Medication Selection, Adherence, Dose Tailoring and Monitoring

Plymouth, MI – May 23, 2022 – Phenomics Health Inc., a bioinformatics-based precision medicine company, today announced the commercial integration of six PrecīsMed® pharmacometabolomic (PMx) and PredictScript™ pharmacogenomic (PGx) clinical…
Read More Phenomics Health Advances Precision Medicine with Products that Integrate Medication Selection, Adherence, Dose Tailoring and Monitoring

Phenomics Health Validates Patented Technology Following Seed Financing

Phenomics Health Inc., a platform bioinformatics-based precision medicine company, today announced completion of clinical product development and validation for its pharmacometabolomics (PMx) PrecīsMed® technology in its new CLIA laboratory located in Michigan Life Science and Innovation Center. The company’s laboratory operations, validation, as well as ongoing research and product development, have been funded with seed financing through experienced healthcare investors.  
Read More Phenomics Health Validates Patented Technology Following Seed Financing